Sunday, Nov 22, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Health | Indian Origin Researcher Develops Antiviral Therapy That Block Covid Transmission

Indian-origin researcher develops antiviral therapy that block Covid transmission

"To our knowledge, this is the only single-dose antiviral that reduces not only symptoms and severity of Covid-19, but also shedding of the virus," said Chaturvedi, first author of the paper.

By IANS
Published Date - 10 September 2022, 01:30 PM
Indian-origin researcher develops antiviral therapy that block Covid transmission
Representational Image.
whatsapp facebook twitter telegram

San Francisco: A team of US scientists, including research investigator Sonali Chaturvedi, has developed a single-dose, intranasal treatment that not only reduces symptoms of multiple Covid variants but also shedding of the virus.

In a new study published in Proceedings of the National Academy of Sciences, the team from Gladstone Institutes in San Francisco showed that this new treatment, called a therapeutic interfering particle (TIP), also decreases the amount of virus shed from infected animals and limits transmission of the virus.

Also Read

  • Hyderabad-based Zenara Pharma launches Covid tablets combi-pack
  • India’s first intranasal vaccine for Covid gets DCGI approval
  • India records 5,910 new COVID-19 cases, 16 fatalities

“To our knowledge, this is the only single-dose antiviral that reduces not only symptoms and severity of Covid-19, but also shedding of the virus,” said Chaturvedi, first author of the paper.

Historically, it has been exceptionally challenging for antivirals and vaccines to limit the transmission of respiratory viruses, including SARS-CoV-2.

“This study shows that a single, intranasal dose of TIPs reduces the amount of virus transmitted, and protects animals that came into contact with that treated animal,” said Gladstone senior investigator Leor Weinberger.

The benefit of TIPs, though, goes beyond their ability to stifle a virus inside infected cells.

Since TIPs reside inside the same cells as the virus they target, they evolve at the same time, staying active even as new viral strains emerge.

“Over the last few years, many of the challenges of the pandemic have been related to the emergence of new variants,” said Chaturvedi.

“TIPs would be an ideal treatment because they keep learning as the virus evolves, so they could keep the problem of drug resistance in check,” she noted.

In the new paper, Weinberger and Chaturvedi studied whether TIPs could also reduce viral shedding — a separate question from reducing symptoms and viral load.

The researchers treated hamsters infected with Covid with the antiviral TIPs and then measured the amount of virus in the animals’ noses daily.

The initial experiments were done using the Delta strain of SARS-CoV-2.

By day 5, all control animals were still shedding high levels of virus, while the virus was undetectable in four out of five TIP-treated animals.

When the infected animals were housed in cages with uninfected animals, treatment of the infected animals with TIPs did not fully prevent the transmission of Covid-19.

However, it did lead to significantly lower viral loads and milder symptoms of infection in the newly exposed animals.

Weinberger’s team is now seeking FDA approval for a clinical trial to test the TIPs in humans.

“Being able to reduce SARS-CoV-2 transmission in this animal setting is quite promising for being able to reduce human-to-human transmission,” said Weinberger from Gladstone, which has an academic affiliation with the University of California, San Francisco.

Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • COVID
  • Covid transmission
  • San Francisco

Related News

  • Storms ravage California coast as ‘Super El Nino’ fuels fears of further damage

    Storms ravage California coast as ‘Super El Nino’ fuels fears of further damage

  • Revanth Reddy government yet to announce financial safeguards against El Nino

    Revanth Reddy government yet to announce financial safeguards against El Nino

  • Telangana faces costly year as El Niño preparedness lags

    Telangana faces costly year as El Niño preparedness lags

  • US judge blocks Trump administration rule limiting stay for foreign students, journalists

    US judge blocks Trump administration rule limiting stay for foreign students, journalists

Latest News

  • Women in Hyderabad’s crime networks: Police cite cases of extortion and trespass

    22 minutes ago
  • Leopard attempts to attack farmer in Vikarabad’s Naskal village

    37 minutes ago
  • KNRUHS reopens BHMS Management Quota applications for 2026-27

    38 minutes ago
  • AIASCT to launch nationwide black badge programme from November 23

    38 minutes ago
  • Nearly 800 children take part in Hyderabad Kids Run 2026

    2 hours ago
  • Hyderabad: Krishna Kanth Park visitors seek sanitation fixes, better facilities during HYDRAA chief’s visit

    37 minutes ago
  • TGSRTC saves Rs 36 crore in diesel costs using i-ALERT technology in 1,500 buses

    36 minutes ago
  • Rashmika Mandanna’s ‘Mysaa’ postponed five days before November 27 release; new date awaited

    1 hour ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App